How to Differentiate Benign versus Malignant Cardiac and Paracardiac ¹⁸F FDG Uptake at Oncologic PET/CT

References

• 1 Opie L, Lopaschuk G. Fuels: aerobic and anaerobic metabolism. In: Opie L, ed. Heart physiology: from cell to circulation. Philadelphia, Pa: Lippincott Williams & Wilkins, 2004; 306–354.
  Google Scholar
• 2 Neely JR, Morgan HE. Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Annu Rev Physiol 1974;36: 413–459.
  Medline Google Scholar
• 3 Herrero P, Gropler RJ. Imaging of myocardial metabolism. J Nucl Cardiol 2005;12(3):345–358.
  Medline Google Scholar
• 4 Abel ED. Glucose transport in the heart. Front Biosci 2004;9:201–215.
  Medline Google Scholar
• 5 Choi Y, Brunken RC, Hawkins RA, et al.. Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans. Eur J Nucl Med 1993;20(4): 308–318.
  Medline Google Scholar
• 6 Paolisso G, Gambardella A, Galzerano D, et al.. Total-body and myocardial substrate oxidation in congestive heart failure. Metabolism 1994;43(2): 174–179.
  Medline Google Scholar
• 7 Taylor M, Wallhaus TR, Degrado TR, et al.. An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in patients with congestive heart failure. J Nucl Med 2001;42(1):55–62.
  Medline Google Scholar
• 8 de Groot M, Meeuwis AP, Kok PJ, Corstens FH, Oyen WJ. Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut. Eur J Nucl Med Mol Imaging 2005; 32(1):98–101.
  Medline Google Scholar
• 9 Ding HJ, Shiau YC, Wang JJ, Ho ST, Kao A. The influences of blood glucose and duration of fasting on myocardial glucose uptake of [18F]fluoro-2-deoxy-d-glucose. Nucl Med Commun 2002;23(10): 961–965.
  Medline Google Scholar
• 10 Kaneta T, Hakamatsuka T, Takanami K, et al.. Evaluation of the relationship between physiological FDG uptake in the heart and age, blood glucose level, fasting period, and hospitalization. Ann Nucl Med 2006;20(3):203–208.
  Medline Google Scholar
• 11 Khandani AH, Isasi CR, Donald Blaufox M. Intra-individual variability of cardiac uptake on serial whole-body 18F-FDG PET. Nucl Med Commun 2005;26(9):787–791.
  Medline Google Scholar
• 12 Berry JJ, Baker JA, Pieper KS, Hanson MW, Hoffman JM, Coleman RE. The effect of metabolic milieu on cardiac PET imaging using fluorine-18-deoxyglucose and nitrogen-13-ammonia in normal volunteers. J Nucl Med 1991;32(8):1518–1525.
  Medline Google Scholar
• 13 Gropler RJ, Siegel BA, Lee KJ, et al.. Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. J Nucl Med 1990;31(11):1749–1756.
  Medline Google Scholar
• 14 Doot RK, Dunnwald LK, Schubert EK, et al.. Dynamic and static approaches to quantifying 18F-FDG uptake for measuring cancer response to therapy, including the effect of granulocyte CSF. J Nucl Med 2007;48(6):920–925.
  Medline Google Scholar
• 15 Inglese E, Leva L, Matheoud R, et al.. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT. J Nucl Med 2007;48(10):1662–1669.
  Medline Google Scholar
• 16 Fukuchi K, Ohta H, Matsumura K, Ishida Y. Benign variations and incidental abnormalities of myocardial FDG uptake in the fasting state as encountered during routine oncology positron emission tomography studies. Br J Radiol 2007;80(949):3–11.
  Medline Google Scholar
• 17 Jingu K, Kaneta T, Nemoto K, et al.. The utility of 18F-fluorodeoxyglucose positron emission tomography for early diagnosis of radiation-induced myocardial damage. Int J Radiat Oncol Biol Phys 2006;66(3):845–851.
  Medline Google Scholar
• 18 Maurer AH, Burshteyn M, Adler LP, Gaughan JP, Steiner RM. Variable cardiac 18FDG patterns seen in oncologic positron emission tomography computed tomography: importance for differentiating normal physiology from cardiac and paracardiac disease. J Thorac Imaging 2011 Jun 21. [Epub ahead of print]
  Google Scholar
• 19 Feygin J, Hu Q, Swingen C, Zhang J. Relationships between regional myocardial wall stress and bioenergetics in hearts with left ventricular hypertrophy. Am J Physiol Heart Circ Physiol 2008;294(5): H2313–H2321.
  Medline Google Scholar
• 20 Williams G, Kolodny G. Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet. AJR Am J Roentgenol 2008;190(2):W151–W156.
  Medline Google Scholar
• 21 Roy FN, Beaulieu S, Boucher L, Bourdeau I, Cohade C. Impact of intravenous insulin on 18F-FDG PET in diabetic cancer patients. J Nucl Med 2009; 50(2):178–183.
  Medline Google Scholar
• 22 Israel O, Weiler-Sagie M, Rispler S, et al.. PET/CT quantitation of the effect of patient-related factors on cardiac 18F-FDG uptake. J Nucl Med 2007;48(2):234–239.
  Medline Google Scholar
• 23 Gontier E, Fourme E, Wartski M, et al.. High and typical 18F-FDG bowel uptake in patients treated with metformin. Eur J Nucl Med Mol Imaging 2008;35(1):95–99.
  Medline Google Scholar
• 24 Jameel MN, Zhang J. Myocardial energetics in left ventricular hypertrophy. Curr Cardiol Rev 2009;5(3):243–250.
  Medline Google Scholar
• 25 Oikawa M, Kagaya Y, Otani H, et al.. Increased [18F]fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol. J Am Coll Cardiol 2005;45(11):1849–1855.
  Medline Google Scholar
• 26 Fujii H, Ide M, Yasuda S, Takahashi W, Shohtsu A, Kubo A. Increased FDG uptake in the wall of the right atrium in people who participated in a cancer screening program with whole-body PET. Ann Nucl Med 1999;13(1):55–59.
  Medline Google Scholar
• 27 Goto K, Okamoto E, Morita M, et al.. Cardiac sarcoidosis detected by FDG-PET [in Japanese]. Nippon Naika Gakkai Zasshi 2005;94(7):1396–1398.
  Medline Google Scholar
• 28 Loukas M, Tubbs RS, Tongson JM, et al.. The clinical anatomy of the crista terminalis, pectinate muscles and the teniae sagittalis. Ann Anat 2008;190(1): 81–87.
  Medline Google Scholar
• 29 Akcay M, Bilen ES, Bilge M, Durmaz T, Kurt M. Prominent crista terminalis: as an anatomic structure leading to atrial arrhythmias and mimicking right atrial mass. J Am Soc Echocardiogr 2007;20(2):197.e9–197.e10.
  Medline Google Scholar
• 30 D'Amato N, Pierfelice O, D'Agostino C. Crista terminalis bridge: a rare variant mimicking right atrial mass. Eur J Echocardiogr 2009;10(3):444–445.
  Medline Google Scholar
• 31 Pandit N, Yeung HW. F-18 FDG pericardial uptake secondary to recent cardiac surgery. Clin Nucl Med 2001;26(11):984–985.
  Medline Google Scholar
• 32 Goethals I, Dierckx R, De Meerleer G, et al.. The role of nuclear medicine in the prediction and detection of radiation-associated normal pulmonary and cardiac damage. J Nucl Med 2003;44(9):1531–1539.
  Medline Google Scholar
• 33 Weber WA. Use of PET for monitoring cancer therapy and for predicting outcome. J Nucl Med 2005; 46(6):983–995.
  Medline Google Scholar
• 34 Kesner A, Lau V, Speiser M, et al.. Time-course of effects of external beam radiation on FDG uptake in healthy tissue and bone marrow [abstr]. J Nucl Med 2007;48(suppl):337P.
  Medline Google Scholar
• 35 Posner MR, Cohen GI, Skarin AT. Pericardial disease in patients with cancer: the differentiation of malignant from idiopathic and radiation-induced pericarditis. Am J Med 1981;71(3):407–413.
  Medline Google Scholar
• 36 Cosset JM, Henry-Amar M, Girinski T, Malaise E, Dupouy N, Dutreix J. Late toxicity of radiotherapy in Hodgkin's disease: the role of fraction size. Acta Oncol 1988;27(2):123–129.
  Medline Google Scholar
• 37 Thurber DL, Edwards JE, Achor RW. Secondary malignant tumors of the pericardium. Circulation 1962;26:228–241.
  Medline Google Scholar
• 38 Grebenc ML, Rosado de Christenson ML, Burke AP, Green CE, Galvin JR. Primary cardiac and pericardial neoplasms: radiologic-pathologic correlation. RadioGraphics 2000;20(4):1073–1103.
  Google Scholar
• 39 Agostini D, Babatasi G, Galateau F, Grollier G, Potier JC, Bouvard G. Detection of cardiac myxoma by F-18 FDG PET. Clin Nucl Med 1999;24(3): 159–160.
  Medline Google Scholar
• 40 Dorsay TA, Ho VB, Rovira MJ, Armstrong MA, Brissette MD. Primary cardiac lymphoma: CT and MR findings. J Comput Assist Tomogr 1993;17(6): 978–981.
  Medline Google Scholar
• 41 Buchmann I, Wandt H, Wahl A, Reske SN. FDG PET for imaging pericardial manifestations of Hodgkin lymphoma. Clin Nucl Med 2003;28(9): 760–761.
  Medline Google Scholar
• 42 Chang CY, Tsai CS, Peng YJ, Huang WS. Large B-cell lymphoma mimicking ischemic heart disease demonstrated by F-18 fluorodeoxyglucose PET/CT in a heart transplant patient. J Nucl Cardiol 2007;14(5):754–757.
  Medline Google Scholar
• 43 Paes FM, Kalkanis DG, Sideras PA, Serafini AN. FDG PET/CT of extranodal involvement in non-Hodgkin lymphoma and Hodgkin disease. RadioGraphics 2010;30(1):269–291.
  Google Scholar
• 44 Weijs LE, Arsos G, Baarslag HJ, Wittebol S, de Klerk JM. Pericardial involvement in a non-Hodgkin lymphoma patient: coregistered FDG-PET and CT imaging. Eur Heart J 2007;28(22):2698.
  Medline Google Scholar
• 45 Zingas AP, Carrera JD, Murray CA, Kling GA. Lipoma of the myocardium. J Comput Assist Tomogr 1983;7(6):1098–1100.
  Medline Google Scholar
• 46 Fan C-M, Fischman AJ, Kwek BH, Abbara S, Aquino SL. Lipomatous hypertrophy of the interatrial septum: increased uptake on FDG PET. AJR Am J Roentgenol 2005;184(1):339–342.
  Medline Google Scholar
• 47 Heyer CM, Kagel T, Lemburg SP, Bauer TT, Nicolas V. Lipomatous hypertrophy of the interatrial septum: a prospective study of incidence, imaging findings, and clinical symptoms. Chest 2003;124(6): 2068–2073.
  Medline Google Scholar
• 48 Kuester LB, Fischman AJ, Fan C-M, Halpern EF, Aquino SL. Lipomatous hypertrophy of the interatrial septum: prevalence and features on fusion 18F fluorodeoxyglucose positron emission tomography/CT. Chest 2005;128(6):3888–3893.
  Medline Google Scholar
• 49 Kaste SC, Howard SC, McCarville EB, Krasin MJ, Kogos PG, Hudson MM. 18F-FDG-avid sites mimicking active disease in pediatric Hodgkin's. Pediatr Radiol 2005;35(2):141–154.
  Medline Google Scholar
• 50 Rao PM, Woodard PK, Patterson GA, Peterson LR. Myocardial metastasis or benign brown fat? Circ Cardiovasc Imaging 2009;2(4):e25–e27.
  Medline Google Scholar
• 51 Tatsumi M, Engles JM, Ishimori T, Nicely O, Cohade C, Wahl RL. Intense (18)F-FDG uptake in brown fat can be reduced pharmacologically. J Nucl Med 2004;45(7):1189–1193.
  Medline Google Scholar
• 52 Weber WA. Brown adipose tissue and nuclear medicine imaging. J Nucl Med 2004;45(7):1101–1103.
  Medline Google Scholar
• 53 Liu Y, Ghesani NV, Zuckier LS. Physiology and pathophysiology of incidental findings detected on FDG-PET scintigraphy. Semin Nucl Med 2010;40(4):294–315.
  Medline Google Scholar
• 54 Zöphel K, Hölzel C, Dawel M, Hölscher T, Evers C, Kotzerke J. PET/CT demonstrates increased myocardial FDG uptake following irradiation therapy. Eur J Nucl Med Mol Imaging 2007;34(8): 1322–1323.
  Medline Google Scholar
• 55 Kühl U, Pauschinger M, Noutsias M, et al.. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction. Circulation 2005;111(7):887–893.
  Medline Google Scholar
• 56 Takano H, Nakagawa K, Ishio N, et al.. Active myocarditis in a patient with chronic active Epstein-Barr virus infection. Int J Cardiol 2008;130(1):e11–e13.
  Medline Google Scholar
• 57 Rybicki BA, Major M, Popovich J, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997;145(3):234–241.
  Medline Google Scholar
• 58 Dannenberg AM. Macrophages in inflammation and infection. N Engl J Med 1975;293(10): 489–493.
  Medline Google Scholar
• 59 Perry A, Vuitch F. Causes of death in patients with sarcoidosis: a morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med 1995;119(2):167–172.
  Medline Google Scholar
• 60 Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978; 58(6):1204–1211.
  Medline Google Scholar
• 61 Teirstein AS, Machac J, Almeida O, Lu P, Padilla ML, Iannuzzi MC. Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis. Chest 2007;132(6): 1949–1953.
  Medline Google Scholar
• 62 Okumura W, Iwasaki T, Toyama T, et al.. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med 2004;45(12):1989–1998.
  Medline Google Scholar
• 63 Sussman SK, Halvorsen RA, Silverman PM, Saeed M. Paracardiac adenopathy: CT evaluation. AJR Am J Roentgenol 1987;149(1):29–34.
  Medline Google Scholar
• 64 Nedergaard J, Bengtsson T, Cannon B. Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab 2007;293(2):E444–E452.
  Medline Google Scholar
• 65 Rao PM, Woodard PK, Patterson GA, Peterson LR. Myocardial metastasis or benign brown fat? Circ Cardiovasc Imaging 2009;2(4):e25–e27.
  Medline Google Scholar
• 66 Yeung HW, Grewal RK, Gonen M, Schöder H, Larson SM. Patterns of (18)F-FDG uptake in adipose tissue and muscle: a potential source of false-positives for PET. J Nucl Med 2003;44(11):1789–1796.
  Medline Google Scholar
• 67 De Winter F, Vogelaers D, Gemmel F, Dierckx RA. Promising role of 18-F-fluoro-D-deoxyglucose positron emission tomography in clinical infectious diseases. Eur J Clin Microbiol Infect Dis 2002;21(4): 247–257.
  Medline Google Scholar
• 68 Yen RF, Chen YC, Wu YW, Pan MH, Chang SC. Using 18-fluoro-2-deoxyglucose positron emission tomography in detecting infectious endocarditis/endoarteritis: a preliminary report. Acad Radiol 2004; 11(3):316–321.
  Medline Google Scholar
• 69 Vind SH, Hess S. Possible role of PET/CT in infective endocarditis. J Nucl Cardiol 2010;17(3): 516–519.
  Medline Google Scholar
• 70 Mäki M, Luotolahti M, Nuutila P, et al.. Glucose uptake in the chronically dysfunctional but viable myocardium. Circulation 1996;93(9):1658–1666.
  Medline Google Scholar
• 71 Vilain D, Bochet J, Le Stanc E, Wattel C, Hameg A, Tainturier C. Unsuspected hibernating myocardium detected by routine oncology (18)F-FDG PET/CT. Eur J Nucl Med Mol Imaging 2010;37(2):409.
  Medline Google Scholar
• 72 Zanco P, Desideri A, Mobilia G, et al.. Effects of left bundle branch block on myocardial FDG PET in patients without significant coronary artery stenoses. J Nucl Med 2000;41(6):973–977.
  Medline Google Scholar